Poseida Therapeutics (PSTX)
(Delayed Data from NSDQ)
$3.37 USD
-0.24 (-6.65%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.37 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.42 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 25.58% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.57 |
Next Year | -1.97 |
EPS (TTM) | -1.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.00M | 15.00M | 84.11M | 30.00M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 15.00M | 15.00M | 84.12M | 50.00M |
Low Estimate | 15.00M | 15.00M | 84.10M | 10.00M |
Year ago Sales | 9.35M | 25.00M | 64.70M | 84.11M |
Year over Year Growth Est. | 60.43% | -40.00% | 29.99% | -64.33% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.42 | -0.45 | -1.57 | -1.97 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.41 | -0.43 | -1.41 | -1.77 |
High Estimate | -0.33 | -0.34 | -1.25 | -1.48 |
Low Estimate | -0.48 | -0.51 | -1.92 | -2.38 |
Year ago EPS | -0.35 | -0.27 | -1.37 | -1.57 |
Year over Year Growth Est. | -20.00% | -66.67% | -14.60% | -25.48% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.42 | -0.45 | -1.57 | -1.97 |
7 Days Ago | -0.42 | -0.45 | -1.57 | -1.97 |
30 Days Ago | -0.42 | -0.45 | -1.57 | -1.97 |
60 Days Ago | -0.40 | -0.43 | -1.61 | -1.94 |
90 Days Ago | -0.40 | -0.43 | -1.61 | -1.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.42 | -0.45 | -1.57 | -1.97 |
Zacks Consensus Estimate | -0.42 | -0.45 | -1.57 | -1.97 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.25 | -0.27 | -0.35 | NA |
Estimate | -0.43 | -0.43 | -0.36 | -0.29 | NA |
Difference | 0.11 | 0.18 | 0.09 | -0.06 | 0.08 |
Surprise | 25.58% | 41.86% | 25.00% | -20.69% | 17.94% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more